Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 7,808 | 6,888 | 5,050 | 5,769 | 17,478 |
| Gross Profit | 7,808 | 6,888 | 5,050 | 5,769 | 17,478 |
| Operating Expenses | 31,660 | 33,520 | 33,244 | 31,227 | 34,559 |
| Operating Income | -23,852 | -26,632 | -28,194 | -25,458 | -17,081 |
| Other Income | 4,730 | 3,653 | 3,178 | 3,338 | 3,474 |
| Pre-tax Income | -19,122 | -22,979 | -25,016 | -22,120 | -13,607 |
| Income Tax | N/A | N/A | N/A | 1,986 | 738 |
| Net Income Continuous | -19,122 | -22,979 | -25,016 | -24,106 | -14,345 |
| Net Income | $-19,122 | $-22,979 | $-25,016 | $-24,106 | $-14,345 |
| EPS Basic Total Ops | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 |
| EPS Basic Continuous Ops | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 |
| EPS Diluted Total Ops | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 |
| EPS Diluted Continuous Ops | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.45 | -0.59 | N/A | N/A |
| EBITDA(a) | $-24,904 | $-26,546 | $-27,913 | $-25,101 | $-16,872 |